Amgen 20 avr. 2026 Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen 20 avr. 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
Pfizer 20 avr. 2026 Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source - South China Morning Post
Amgen 16 avr. 2026 Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
FierceBiotech 14 avr. 2026 Boehringer, Amgen discard early immunology candidates over lack of clinical potential
BioPharma Dive 6 avr. 2026 Under-the-skin Tepezza comparable to infused version in key study, Amgen says
Endpoints News 6 avr. 2026 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
FierceBiotech 30 mars 2026 Viridian’s other rival to Amgen’s Tepezza scores phase 3 win, but investors need convincing
BioPharma Dive 4 févr. 2026 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
FierceBiotech 4 févr. 2026 Amgen advances toward lupus redemption while gastric cancer candidate struggles